IRIS
Demichelis, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.435
AS - Asia 4.520
EU - Europa 3.639
SA - Sud America 814
AF - Africa 111
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 9
Totale 23.565
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.260
SG - Singapore 1.893
CN - Cina 842
VN - Vietnam 731
IT - Italia 690
BR - Brasile 672
RU - Federazione Russa 542
FI - Finlandia 424
DE - Germania 357
SE - Svezia 313
GB - Regno Unito 312
HK - Hong Kong 272
UA - Ucraina 272
FR - Francia 216
LV - Lettonia 160
KR - Corea 145
IN - India 137
CA - Canada 113
BD - Bangladesh 78
ID - Indonesia 70
BG - Bulgaria 58
AR - Argentina 57
ES - Italia 54
IQ - Iraq 54
JP - Giappone 48
NL - Olanda 48
ZA - Sudafrica 46
TR - Turchia 43
PL - Polonia 42
AT - Austria 40
MX - Messico 40
JO - Giordania 37
AU - Australia 32
PK - Pakistan 30
LU - Lussemburgo 22
VE - Venezuela 20
PH - Filippine 17
MA - Marocco 16
CO - Colombia 15
UZ - Uzbekistan 14
EC - Ecuador 13
LT - Lituania 13
AE - Emirati Arabi Uniti 12
CL - Cile 11
CZ - Repubblica Ceca 11
IE - Irlanda 11
PY - Paraguay 11
BE - Belgio 10
NP - Nepal 10
SA - Arabia Saudita 10
KE - Kenya 9
TH - Thailandia 9
TN - Tunisia 9
CH - Svizzera 8
LB - Libano 8
EG - Egitto 7
IL - Israele 7
RO - Romania 7
UY - Uruguay 7
PE - Perù 6
TW - Taiwan 6
AZ - Azerbaigian 5
DZ - Algeria 5
ET - Etiopia 5
IR - Iran 5
NG - Nigeria 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
A2 - ???statistics.table.value.countryCode.A2??? 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
KG - Kirghizistan 4
KH - Cambogia 4
KZ - Kazakistan 4
OM - Oman 4
EU - Europa 3
GT - Guatemala 3
JM - Giamaica 3
MY - Malesia 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
AO - Angola 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CI - Costa d'Avorio 2
EE - Estonia 2
GA - Gabon 2
GR - Grecia 2
HR - Croazia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
MD - Moldavia 2
MT - Malta 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
TJ - Tagikistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 23.546
Salva come PNG Salva come JPEG
Città #
Fairfield 1.720
Ashburn 1.473
Singapore 1.143
Chandler 956
Woodbridge 790
Seattle 707
San Jose 667
Houston 639
Jacksonville 611
Cambridge 587
Wilmington 569
Dallas 451
Santa Clara 371
San Mateo 334
Ann Arbor 330
Columbus 313
Helsinki 270
Los Angeles 252
Moscow 246
Hong Kong 243
Princeton 227
Trento 213
Beijing 199
The Dalles 193
New York 192
Ho Chi Minh City 187
Hanoi 175
Riga 160
Munich 156
Council Bluffs 149
Lauterbourg 142
Seoul 134
San Diego 120
Boardman 108
London 98
Dearborn 79
Chicago 74
Lawrence 70
Orem 70
Buffalo 69
São Paulo 64
Milan 62
Jakarta 60
San Francisco 58
Sofia 58
Como 56
Dong Ket 50
Da Nang 43
Nuremberg 42
Frankfurt am Main 41
Falls Church 40
Redondo Beach 39
Chennai 38
Montreal 35
Tokyo 35
Bremen 34
Hefei 34
Denver 32
Salt Lake City 32
Warsaw 32
Phoenix 31
Toronto 31
Johannesburg 29
Brooklyn 28
Boston 27
Norwalk 27
San Paolo di Civitate 27
Brasília 24
Atlanta 23
Haiphong 23
Tolentino 23
Washington 23
Guangzhou 22
Hesperange 22
Rome 22
Altamura 21
Belo Horizonte 21
Des Moines 21
Shanghai 21
Turku 21
Baghdad 20
Bend 20
Dublin 20
Elk Grove Village 19
Melbourne 19
Rio de Janeiro 19
Curitiba 17
Manchester 17
Mumbai 17
Barcelona 16
Changsha 16
Izmir 16
Kilburn 16
Vienna 16
Düsseldorf 15
Lappeenranta 15
Vancouver 15
Amsterdam 13
Andover 13
New Delhi 13
Totale 17.191
Salva come PNG Salva come JPEG
Nome #
Hit and go CAS9 delivered through a lentiviral based self-limiting circuit 376
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer 362
Inherited determinants of early recurrent somatic mutations in prostate cancer 332
A highly specific SpCas9 variant is identified by in vivo screening in yeast 320
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancer 314
Genomic correlates of clinical outcome in advanced prostate cancer 277
ETS-related gene (ERG) undermines genome stability in mouse prostate progenitors via Gsk3β dependent Nkx3.1 degradation 271
Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study 248
Personalized in vitro and in vivo cancer models to guide precision medicine 247
ASEQ: Fast allele-specific studies from next-generation sequencing data 242
Ultrasensitive detection of cancer biomarkers by nickel-based isolation of polydisperse extracellular vesicles from blood 238
Patient derived organoids to model rare prostate cancer phenotypes 236
A novel brain tumour model in zebrafish reveals the role of YAP activation in MAPK- and PI3K-induced malignant growth 236
N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer 225
EthSEQ: ethnicity annotation from whole exome sequencing data 223
Second Generation Imaging of Nuclear/Cytoplasmic HIV-1 Complexes. 222
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers 222
Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer 211
An evaluation of the use of and user satisfaction with a teleconsultation system in oncology practice. 208
RB1 heterogeneity in advanced metastatic castration-resistant prostate cancer 205
Analysis of user-satisfaction with the use of a teleconsultation system in oncology. 201
Ancestry-specific predisposing germline variants in cancer 201
Allele-specific genomic data elucidate the role of somatic gain and copy-number neutral loss of heterozygosity in cancer 195
The long tail of oncogenic drivers in prostate cancer 189
PaCBAM: Fast and scalable processing of whole exome and targeted sequencing data 186
An automated procedure to properly handle digital images in large scale tissue microarray experiments. 183
Clonal evolution of chemotherapy-resistant urothelial carcinoma 183
TPES: Tumor Purity Estimation from SNVs 179
A computational framework discovers new copy number variants with functional importance. 173
The Molecular Taxonomy of Primary Prostate Cancer 173
In-silico identification and functional validation of allele-dependent AR enhancers 171
ABEMUS: platform-specific and data-informed detection of somatic SNVs in cfDNA 170
Sterile inflammation via TRPM8 RNA-dependent TLR3-NF-kB/IRF3 activation promotes antitumor immunity in prostate cancer 168
High-throughput sequencing of two populations of extracellular vesicles provides an mRNA signature that can be detected in the circulation of breast cancer patients 167
A step toward functionally characterized prostate cancer molecular subtypes. 166
Charting differentially methylated regions in cancer with Rocker-meth 166
Molecular sampling of prostate cancer: a dilemma for predicting disease progression. 165
Core Biopsies from Prostate Cancer Patients in Active Surveillance Protocols Harbor PTEN and MYC Alterations 164
The landscape of somatic copy-number alteration across human cancers. 163
Defining order and timing of mutations during cancer progression: The TO-DAG probabilistic graphical model 162
Antibody-based detection of ERG rearrangement-positive prostate cancer. 160
N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer. 160
Analytical protocol to identify local ancestry-associated molecular features in cancer 158
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. 157
A hierarchical Naïve Bayes Model for handling sample heterogeneity in classification problems: an application to tissue microarrays. 153
Fast mutual exclusivity algorithm nominates potential synthetic lethal gene pairs through brute force matrix product computations 153
A Comparative Study of ERG Status Assessment on DNA, mRNA, and Protein Levels Using Unique Samples from a Swedish Biopsy Cohort. 152
Testing mutual exclusivity of ETS rearranged prostate cancer. 150
Genomic correlates to the newly proposed grading prognostic groups for prostate cancer 148
Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer 148
Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets 147
Genome-wide linkage analysis of TMPRSS2-ERG fusion in familial prostate cancer. 147
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma. 147
Digital Pathology: Science Fiction? 146
Tumor purity quantification by clonal DNA methylation signatures 146
EML4-ALK fusion lung cancer: a rare acquired event. 145
Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthase. 144
Plasma AR and abiraterone-resistant prostate cancer 144
Role of non-coding sequence variants in cancer 144
Variants at IRX4 as prostate cancer expression quantitative trait loci. 142
Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer. 142
Better screened than sorry!-an informed panel of inherited DNA repair gene variants for prostate cancer screening and prognostication 142
M-CAM expression as marker of poor prognosis in epithelial ovarian cancer. 141
Automated immunofluorescence analysis defines microvessel area as a prognostic parameter in clear cell renal cell cancer. 139
SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer. 139
Recurrent prostate cancer genomic alterations predict response to brachytherapy treatment 139
The genomic complexity of primary human prostate cancer. 139
Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. 139
Oncogene-mediated alterations in chromatin conformation 138
Punctuated evolution of prostate cancer genomes. 137
TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. 137
Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease. 137
The virtual case: a new method to completely digitize cytological and histological slides. 137
JAGGED1 expression is associated with prostate cancer metastasis and recurrence. 136
Association of cytokeratin 7 and 19 expression with genomic stability and favorable prognosis in clear cell renal cell cancer. 136
Large Oncosomes in Human Prostate Cancer Tissues and in the Circulation of Mice with Metastatic Disease 136
Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF_SELECT consortium assay 136
Nine-gene molecular signature is not associated with prostate cancer death in a watchful waiting cohort. 135
TMPRSS2-ERG fusion heterogeneity in multifocal prostate cancer: clinical and biologic implications. 135
TMABoost: an integrated system for comprehensive management of tissue microarray data. 135
Digital storage of glass slides for quality assurance in histopathology and cytopathology. 135
Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA Methylation 134
Large oncosomes mediate intercellular transfer of functional microRNA. 134
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer 134
PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer 134
User attitudes in analyzing digital slides in a quality control test bed: a preliminary study. 133
Epigenetic Repression of miR-31 Disrupts Androgen Receptor Homeostasis and Contributes to Prostate Cancer Progression 133
Robotic telepathology for intraoperative remote diagnosis using a still-imaging-based system. 133
Next-generation rapid autopsies enable tumor evolution tracking and generation of preclinical models 133
Integrating extracellular vesicle and circulating cell-free DNA analysis on a single plasma aliquot improves the detection of HER2 positivity in breast cancer patients 132
Tumor clone dynamics in lethal prostate cancer 132
Mutation–selection balance and compensatory mechanisms in tumour evolution 132
Skp2 expression is associated with high risk and elevated Ki67 expression in gastrointestinal stromal tumours. 131
Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancer. 130
Optimizing copy number variation analysis using genome-wide short sequence oligonucleotide arrays. 130
ERG cooperates with androgen receptor in regulating trefoil factor 3 in prostate cancer disease progression. 130
Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer care 129
Exome sequencing of African-American prostate cancer reveals loss-of-function ERF mutations 129
Comparative genomics of primary prostate cancer and paired metastases: insights from 12 molecular case studies 129
Design and initial implementation of a regional tele-oncology project. 128
Totale 17.121
Salva come PNG Salva come JPEG
Categoria #
all - tutte 99.592
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 778
selected - selezionate 0
volume - volumi 458
Totale 100.828
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021271 0 0 0 0 0 0 0 0 0 0 0 271
2021/20222.157 249 327 14 92 36 81 83 390 137 212 181 355
2022/20232.024 267 235 13 328 210 316 30 145 252 34 122 72
2023/2024822 49 77 67 28 76 177 45 92 10 80 32 89
2024/20253.676 18 36 235 669 246 461 205 220 390 578 281 337
2025/20268.172 632 263 978 1.087 869 542 1.454 235 757 620 488 247
Totale 23.929